Investment Summary

Exits Arise Virtual Solutions

On July 1, 2005, invested in information technology company Arise Virtual Solutions from Easton Capital Investment Group

Investment Highlights
  • This is transaction in the Information Technology sector.
  • This is transaction in the United States.
  • This is transaction in Florida.
Investment Fate
  • Arise Virtual Solutions was sold to a financial buyer in 2018.
  • Arise Virtual Solutions was sold to a strategic buyer in 2019.

Investment Summary

Date 2005-07-01
Target Arise Virtual Solutions
Sector Information Technology
Sellers(s) Easton Capital Investment Group
Deal Type Stake Sale

Target

Arise Virtual Solutions

Miramar, Florida, United States
website
Arise's corporate headquarters in Miramar, Florida.
Arise's corporate headquarters in Miramar, Florida.
Arise Virtual Solutions, Inc. is a pioneer of on-demand customer management business process outsourcing solutions. Arise powerful cloud-based platform connects companies needing customer engagement and other business services to a virtual nationwide network of work-at-home Service Partners running small call center businesses.

Search 177,612 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Seller(S) 1

SELLER

Easton Capital Investment Group

New York, New York, United States

Investor Investor Investor Investor Investor

website


Category Venture Capital Firm
Founded 2000
PE ASSETS 200M USD
Size Small
Type Sector Focused
DESCRIPTION

Easton Capital Investment Group is a private investment firm that targets early-stage venture capital to later-stage growth capital investments. Easton will consider opportunities across a range of industries but generally invests in the healthcare industry, including biopharmaceuticals, drug delivery, medical devices, and healthcare services. Easton looks to commit $0.50 to $10 million per transaction. Easton Capital was formed in 2000 and is based in New York.


DEAL STATS #
Overall 3 of 20
Sector (Information Technology) 1 of 1
Type (Stake Sale) 1 of 1
State (Florida) 1 of 1
Country (United States) 3 of 20
Year (2005) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-06-14 Salmedix

San Diego, California, United States

Salmedix was a late stage biopharmaceutical company focusing on in-licensing and development of cancer products. The Company?s lead product, SDX-105, was in Phase II/III clinical trials for non-Hodgkin?s lymphoma at the time of Easton's investment. In addition, Salmedix had two drugs in Phase II clinical development, as well as several preclinical product candidates.

Sell $160M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2005-08-24 Protez Pharmaceuticals

Malvem, Pennsylvania, United States

Protez Pharmaceuticals, Inc. is a drug development company focused on novel antibiotics for the hospital market. Key program areas for Protez include a breakthrough broad spectrum carbapenem and two combination strategies for product line extensions of multiple established antibiotics.

Buy -